HKU Scholars Hub: Browsing DSpace

Browsing by Author Meyer, T

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 1 to 5 of 5

	Title	Author(s)	Issue Date	Views
	First-in-Human Phase I Study of Fisogatinib (BLU-554) Validates Aberrant FGF19 Signaling as a Driver Event in Hepatocellular Carcinoma Journal:Cancer Discovery	Kim, RD Sarker, D Meyer, T Yau, T Macarulla, T Park, JW Choo, SP Hollebecque, A Sung, MW Lim, HY Mazzaferro, V Trojan, J Zhu, AX Yoon, JH Sharma, S Lin, ZZ Chan, SL Faivre, S Feun, LG Yen, C-J Dufour, J-F Palmer, DH Llovet, JM Manoogian, M Tugnait, M Stransky, N Hagel, M Kohl, NE Lengauer, C Sherwin, CA Schmidt-Kittler, O Hoeflich, KP Shi, H Wolf, BB Kang, Y-K	2019	20
	Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial Journal:Lancet	El-Khoueiry, AB Sangro, B Yau, TCC Crocenzi, TS Kudo, M Hsu, C Kim, TY Choo, SP Trojan, J Welling, TH Meyer, T Kang, YK Yeo, W Chopra, A Anderson, J Dela Cruz, C Lang, L Neely, J Tang, H Dastani, HB Melero, I	2017	19
	Safety and Antitumor Activity of Nivolumab (Nivo) in Patients (pts) with Advanced Hepatocellular Carcinoma (HCC): Interim Analysis of Dose-Expansion Cohorts from the Phase 1/2 CheckMate-040 Study Proceeding/Conference:Liver Cancer	Sangro, B Melero, I Yau, TCC Hsu, C Kudo, M Crocenzi, TS Kim, TY Choo, SP Trojan, J Meyer, T Kang, YK Anderson, J dela Cruz, C Lang, L Neely, J El-Khoueiry, AB	2016	216
	Second-line cabozantinib after sorafenib treatment for advanced hepatocellular carcinoma: a subgroup analysis of the phase 3 CELESTIAL trial Journal:ESMO Open	Kelley, RK Ryoo, BY Merle, P Park, JW Bolondi, L Chan, SL Lim, HY Baron, AD Parnis, F Knox, J Cattan, S Yau, T Lougheed, JC Milwee, S El-Khoueiry, AB Cheng, AL Meyer, T Abou-Alfa, GK	2020	2
	Serum alpha-fetoprotein levels and clinical outcome in the phase 3 CELESTIAL study of cabozantinib versus placebo in patients with advanced hepatocellular carcinoma Journal:Clinical Cancer Research	Kelley, RK Meyer, T Rimassa, L Merle, P Park, JW Yau, T Chan, SL Blanc, JF Tam, VC Tran, A Dadduzio, V Markby, DW Kaldate, R Cheng, AL El-Khoueiry, AB Abou-Alfa, GK	2020	6

Showing results 1 to 5 of 5